HXSA 902 is a topical haemostat/wound sealant designed to seal incisions and control bleeding in surgery, as well treat trauma wounds. The demand for topical haemostats / wound sealants is growing rapidly, driven by the introduction of minimally invasive surgical techniques and the need to reduce the duration of surgical procedures.

HXSA 902 is based on the company’s unique fibrinogen-binding technology which provides a new toolbox for applications in the field of localised haemostasis.  HXSA 902 forms a gel matrix with fibrinogen that exhibits novel bio-mechanical properties. The gel is formed without the need for the enzyme thrombin or undesirable chemical cross-linkers, required in other haemostats or sealants. The product offers simplicity, low cost, biocompatibility and new biomechanical properties.

HXSA 902 is based on the company’s patented fibrinogen-binding peptide technology More...